Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sales

1,854.50

1,979.00

1,857.57

1,674.15

1,537.44

Operating profit

98.48

76.63

187.32

210.04

139.03

Interest

138.68

74.24

65.34

66.71

54.09

Gross profit

43.86

125.87

210.98

243.49

199.55

EPS (Rs)

0.52

20.07

8.72

12.47

12.32

Other income

84.07

123.49

89.00

100.16

114.61

Stock adjustment

21.04

114.26

-117.53

1.18

-45.52

Raw material

1,020.10

935.42

1,050.10

848.34

903.77

Power and fuel

-

-

-

-

-

Employee expenses

267.01

272.09

272.72

221.77

223.21

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

447.87

580.60

464.96

392.82

316.95

Provisions made

-

-

-

-

-

Depreciation

93.62

104.37

99.34

91.63

83.00

Taxation

-69.44

-158.68

33.40

40.16

-1.38

Net profit / loss

4.68

180.19

78.24

111.70

110.37

Extra ordinary item

-15.00

-

-

-

-7.56

Prior year adjustments

-

-

-

-

-

Equity capital

90.30

89.79

89.68

89.55

89.55

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

5.31

3.87

10.08

12.55

9.04

GPM (%)

2.26

5.99

10.84

13.72

12.08

NPM (%)

0.24

8.57

4.02

6.30

6.68